DURECT Corporation (DRRX) Stock Analysis
DELISTED 2025
What happened to DURECT Corporation (DRRX) stock?
DURECT Corporation (DRRX) no longer trades on public markets. It was delisted in September 2025. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
- Delisting date:
- September 2025
- Last recorded price (historical):
- $1.91 (last quote on record before the September 2025 delisting; historical, not a current quote)
P/E 73.47 means the share price is 73.47 times one year of earnings per share. Market cap $59.3M is the value of all shares combined.
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
DURECT Corporation (DRRX). DURECT Corporation is a biopharmaceutical company focused on researching and developing innovative medicines. Their diverse product portfolio includes ALZET osmotic pumps, larsucosterol (DUR-928), POSIMIR, and Methydur, targeting unmet medical needs.
Last analyzed: May 10, 2026Dated analysis: the newest financial statements on file are 25 months old (Sep 1, 2024), so the figures and score below describe that period, not today.
DURECT Corporation (DRRX) Healthcare & Pipeline Overview
More about this archive record
Can I still buy DRRX shares?
No. DRRX stopped trading on public markets in September 2025, so the shares are not available through a broker. Anything you see quoted for DRRX elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before DRRX stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to DURECT Corporation. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.